Finance

Lists
ATOS:NASDAQ
Atossa Therapeutics Inc
$1.92
+1.59%
(+0.030) 1D
Nov 18, 12:50:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATOS...
Open
$1.85
High
$1.92
Low
$1.85
Mkt. cap
19.16M
Avg. vol.
81.57K
Volume
12.60K
52-wk high
$14.85
52-wk low
$1.70
EPS
-$4.34
Beta
1.38
Shares outstanding
9.98M
No. of employees
16
Open
$1.85
High
$1.92
Low
$1.85
Mkt. cap
19.16M
Avg. vol.
81.57K
Volume
12.60K
52-wk high
$14.85
52-wk low
$1.70
EPS
-$4.34
Beta
1.38
Shares outstanding
9.98M
No. of employees
16
News stories
From web sources and news partners
About Atossa Therapeutics Inc
CEOSteven C. Quay
Employees16
Founded2008
HeadquartersSeattle, Washington, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 2 analysts giving stock ratings to ATOS in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ATOS in the last 3 months.
Highest
Current $1.92
$25.00 (+1,202.08%)
Average
$17.50 (+811.46%)
Lowest
$10.00 (+420.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+420.8%
11/10/2026
Edward Woo
Ascendiant
Buy
Maintained
$25.00
+1,202.1%
09/30/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$12.00
+525%
07/07/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$25.00
+1,202.1%
05/08/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$10.00
+420.8%
02/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.16M
4.78M
4.90M
3.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.28M
5.09M
3.80M
2.52M
Operating expense
11.44M
9.87M
8.69M
5.90M
Total operating expenses
11.44M
9.87M
8.69M
5.90M
Operating income
-11.44M
-9.87M
-8.69M
-5.90M
Other non operating income
57.00K
-28.00K
-24.00K
52.00K
EBT including unusual items
-10.94M
-9.59M
-8.49M
-5.64M
EBT excluding unusual items
-10.94M
-9.59M
-8.49M
-5.64M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.94M
-9.59M
-8.49M
-5.64M
Net profit margin
-
-
-
-
Earnings per share
-1.34
-1.11
-0.95
-0.56
Interest and investment income
442.00K
309.00K
227.00K
209.00K
Interest expense
-
-
-
-
Net interest expenses
442.00K
309.00K
227.00K
209.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.43M
-9.87M
-8.69M
-5.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps